Citations

Institution: Mayo Clinic Clear

Showing 10 of 107890 citations.

Early-onset peripheral arterial occlusive disease: clinical features and determinants of disease severity and location
Barretto, Simone N., Rooke, Thom W. , Ballman, Karla V. , Kullo, Iftikhar J.

Vascular Medicine | November 12, 2003 | Volume: 8 | Issue: 2 | Pages: 95-100

10.1191/1358863x03vm475oa | PMID 14518611 Get It

Early-onset peripheral lower extremity arterial occlusive disease (PAD) is an uncommon, poorly characterized manifestation of atherosclerotic vascular disease. We studied the clinical presentation and correlates of disease severity and location in patients with early-onset PAD identifi ed at non-invasive arterial evaluation. We identifi ed a series of 159 patients who were younger than 50 years and had an abnormal resting or postexercise ankle brachial index (ABI) (<0.9) or, if arteries were noncompressible, monophasic arterial Doppler signals. Disease severity and location were determined based on results of noninvasive vascular laboratory testing. Presence of coexisting atherosclerosis in other arterial beds was ascertained by review of patient records. Multivariable logistic regression analyses were used to identify risk factors associated with disease severity and location. Mean age of the patients was 42.7 6 4.2 years and 55% were women. Prevalence of risk factors was 76% for current or past smoking; 71%, dyslipidemia; 53%, hypertension; 35%, diabetes; and 53%, family history. Claudication was present in 50%, rest pain in 3%, ulceration in 31% and the remaining 16% did not have symptoms from PAD. Low high-density lipoprotein (HDL)-cholesterol and female sex were associated with severity. Of 102 patients in whom disease location could be determined noninvasively, 65% had aortoiliac disease. Female sex, low HDL-cholesterol, and absence of diabetes were associated with aortoiliac disease. Atherosclerosis in other arterial beds was identifi ed in 53% of the patients. Conclusion: In this study population of early-onset atherosclerotic PAD, men and women were equally represented. The disease involved predominantly the aortoiliac location. Low HDL-cholesterol and female sex were associated with disease severity. An aggressive approach to diagnosis and treatment may be warranted as atherosclerosis in other arterial beds was prevalent in half of the patients.
Are our data symmetric?
Mandrekar, Sumithra J. , Mandrekar, Jayawant N.

Statistical Methods in Medical Research | November 12, 2003 | Volume: 12 | Issue: 6 | Pages: 505-513

10.1191/0962280203sm346oa | PMID 14653353 Get It

Skewness indicates a lack of symmetry in a distribution. Knowing the symmetry of the underlying data is essential for parametric analysis, fitting distributions or doing transformations to the data. The coefficient of skewness is the commonly used measure to identify a lack of symmetry in the underlying data, although graphical procedures can also be effective. We discuss three different methods to assess skewness: traditional coefficient of skewness index, skewness index based on the L-moments discussed by Hosking and the asymptotic test of symmetry developed by Randles et al. With this work, we provide easy-to-implement S-PLUS functions as well as discuss the advantages and shortcomings of each technique.
Lupus nephritis in children
Gloor, J.M.

Lupus | November 12, 2003 | Volume: 7 | Issue: 9 | Pages: 639-643

10.1191/096120398678920785 | PMID 9884103 Get It

The renal manifestations of systemic lupus erythematosus in childhood range from minor abnormalities detected on urinalysis to severe renal insufficiency requiring renal replacement therapy. Clinically significant renal involvement in systemic lupus erythematosus is more common in children than in adults. Effective treatment for childhood lupus nephritis is available, and the prognosis for affected children has improved over the course of the last 30 years. Corticosteroid therapy remains the cornerstone of treatment for children with lupus nephritis. The addition of cytotoxic agents to corticosteroid treatment improves both the long and short-term prognoses. Cyclosporin may improve the clinical manifestations of lupus nephritis although the disease remains active serologically. Although survival in childhood lupus has improved, complications of therapy result in significant morbidity with distressing frequency. Immunosuppression may result in mortality and morbidity due to opportunistic infections. Individuals with otherwise successful control of renal manifestations of systemic lupus erythematosus may still be left with significant morbidity due to disturbances in growth due to long-term corticosteroid treatment. Psychosocial development may be adversely affected both as a result of chronic illness as well as due to the effects of therapy. Meticulous attention to detail over decades of treatment is necessary to optimize patient outcome in childhood lupus nephritis.
Giant cell arteritis
Hunder, Gene G.

Lupus | November 12, 2003 | Volume: 7 | Issue: 4 | Pages: 266-269

10.1191/096120398678920073 | PMID 9643316 Get It

In many populations giant cell arteritis (GCA) is the most common form of vasculitis. Genetic markers, ethnic factors, and increasing age over 50 years appear to enhance susceptibility and an infection may trigger its onset. Recent investigations provide evidence that the vasculitic reaction is part of an immune response to an antigen residing in involved artery walls. These studies along with the description of an experimental model of the disease have significantly increased out understanding of GCA.
Cell-Type-Specific Activation of PAK2 by Transforming Growth Factor β Independent of Smad2 and Smad3
Wilkes, Mark C. , Garamszegi, Nandor, Leof, Edward B. , Murphy, Stephen J.

Molecular and Cellular Biology | November 11, 2003 | Volume: 23 | Issue: 23 | Pages: 8878-8889

10.1128/mcb.23.23.8878-8889.2003 | PMID 14612425 Get It

HLA and H2 Class II Transgenic Mouse Models to Study Susceptibility and Protection in Autoimmune Thyroid Disease
Kong, Yi-chi M., Flynn, Jeffrey C. , Wan, Qiang , David, Chella S.

Autoimmunity | November 11, 2003 | Volume: 36 | Issue: 6-7 | Pages: 397-404

10.1080/08916930310001603028 | PMID 14669947 Get It

Obesity, Sleep Apnea, and Hypertension
Wołk, Robert , Shamsuzzaman, Abu, Somers, Virend K.

Hypertension | November 11, 2003 | Volume: 42 | Issue: 6 | Pages: 1067-1074

10.1161/01.hyp.0000101686.98973.a3 | PMID 14610096 Get It

Obesity has a high and rising prevalence and represents a major public health problem. Obstructive sleep apnea (OSA) is also common, affecting an estimated 15 million Americans, with a prevalence that is probably also rising as a consequence of increasing obesity. Epidemiologic data support a link between obesity and hypertension as well as between OSA and hypertension. For example, untreated OSA predisposes to an increased risk of new hypertension, and treatment of OSA lowers blood pressure, even during the daytime. Possible mechanisms whereby OSA may contribute to hypertension in obese individuals include sympathetic activation, hyperleptinemia, insulin resistance, elevated angiotensin II and aldosterone levels, oxidative and inflammatory stress, endothelial dysfunction, impaired baroreflex function, and perhaps by effects on renal function. The coexistence of OSA and obesity may have more widespread implications for cardiovascular control and dysfunction in obese individuals and may contribute to some of the clustering of abnormalities broadly defined as the metabolic syndrome. From the clinical and therapeutic perspectives, the presence of resistant hypertension and the absence of a nocturnal decrease in blood pressure in obese individuals should prompt the clinician to consider the diagnosis of OSA, especially if clinical symptoms suggestive of OSA (such as poor sleep quality, witnessed apnea, excessive daytime somnolence, and so forth) are also present.
Diverse Origin and Function of Cells With Endothelial Phenotype Obtained From Adult Human Blood
Gulati, Rajiv , Jevremović, Dragan , Peterson, Timothy E., Chatterjee, Suvro , Shah, Vijay H. , Vile, Richard G. , Simari, Robert D., Jevremovic, Dragan

Circulation Research | November 11, 2003 | Volume: 93 | Issue: 11 | Pages: 1023-1025

10.1161/01.res.0000105569.77539.21 | PMID 14605020 Get It

Cells with endothelial phenotype generated from adult peripheral blood have emerging diagnostic and therapeutic potential. This study examined the lineage relationship between, and angiogenic function of, early endothelial progenitor cells (EPCs) and late outgrowth endothelial cells (OECs) in culture. Culture conditions were established to support the generation of both EPCs and OECs from the same starting population of peripheral blood mononuclear cells (PBMCs). Utilizing differences in expression of the surface endotoxin receptor CD14, it was determined that the vast majority of EPCs arose from a CD14 + subpopulation of PBMCs but OECs developed exclusively from the CD14 − fraction. Human OECs, but not EPCs, expressed key regulatory proteins endothelial nitric oxide synthase (eNOS) and caveolin-1. Moreover, OECs exhibited a markedly greater capacity for capillary morphogenesis in in vitro and in vivo matrigel models, tube formation by OECs being in part dependent on eNOS function. Collectively, these data indicate lineage and functional heterogeneity in the population of circulating cells capable of assuming an endothelial phenotype and provide rationale for the investigation of new cell-therapeutic approaches to ischemic cardiovascular disease.
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
Dingli, David , Peng, Kah-Whye , Harvey, Mary, Greipp, Philip R., O’Connor, Michael K. , Cattaneo, Roberto , Morris, John C. , Russell, Stephen J. , Dingli, David

Blood | November 11, 2003 | Volume: 103 | Issue: 5 | Pages: 1641-1646

10.1182/blood-2003-07-2233 | PMID 14604966 Get It

AbstractThe Edmonston vaccine strain of measles virus (MV-Edm) propagates efficiently in a broad range of human tumor cells, killing them selectively. However, the oncolytic potency of MV-Edm in different human tumor xenograft therapy models is highly variable and there is no convenient way to map the distribution of virus-infected tissues in vivo. To enhance the oncolytic potency of MV-Edm against radiosensitive malignancies and to facilitate noninvasive imaging of infected tissues, we generated a recombinant MV-Edm encoding the human thyroidal iodide symporter (NIS). MV-NIS replicated almost as efficiently as unmodified MV-Edm, and human tumor cells efficiently concentrated radioiodine when infected with MV-NIS. Intratumoral spread of MV-NIS was noninvasively demonstrated by serial gamma-camera imaging of iodine-123 (123I) uptake both in MV-sensitive KAS-6/1 myeloma xenografts, which regressed completely after a single intravenous dose of MV-NIS, and in MM1 myeloma xenografts, which were unresponsive to MVNIS therapy. However, MV-resistant MM1 tumors regressed completely when 131I was administered 9 days after a single intravenous injection of MV-NIS (radiovirotherapy). 131I alone had no effect on MM1 tumor growth. While the potential hematopoietic toxicity of this new therapy requires further evaluation, image-guided radiovirotherapy is a promising new approach to the treatment of multiple myeloma, an incurable but highly radiosensitive plasma cell malignancy. Testing in other radiosensitive cancers is warranted.
A Ferret Model of Canine Distemper Virus Virulence and Immunosuppression
Messling, Veronika von , Springfeld, Christoph , Devaux, Patricia , Cattaneo, Roberto

Journal of Virology | November 10, 2003 | Volume: 77 | Issue: 23 | Pages: 12579-12591

10.1128/jvi.77.23.12579-12591.2003 | PMID 14610181 Get It

ABSTRACT Canine distemper virus (CDV) infects many carnivores, including ferrets and dogs, and is the member of the Morbillivirus genus most easily amenable to experimentation in a homologous small-animal system. To gain insights into the determinants of CDV pathogenesis, we isolated a strain highly virulent for ferrets by repeated passaging in these animals. Sequence comparison of the genome of this strain with that of its highly attenuated precursor revealed 19 mutations distributed almost evenly in the six genes. We then recovered a virus from a cDNA copy of the virulent CDV strain's consensus sequence by using a modified reverse genetics system based on B cells. We infected ferrets with this virus and showed that it fully retained virulence as measured by the timing of rash appearance, disease onset, and death. Body temperature, leukocyte number, lymphocyte proliferation activity, and cell-associated viremia also had similar kinetics. We then addressed the question of the relative importance of the envelope and other viral constituents for virulence. Viruses in which the envelope genes (matrix, fusion, and hemagglutinin) of the virulent strain were combined with the other genes of the attenuated strain caused severe rash and fever even if the disease onset was delayed. Viruses in which the nucleocapsid, polymerase, and phosphoprotein genes (coding also for the V and C proteins) of the virulent strain were combined with the envelope genes of the attenuated strain caused milder signs of disease. Thus, virulence-inducing mutations have accumulated throughout the genome.